A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus‐ vs. Paclitaxel‐eluting stents in de novo occlusive lesions in coronary arteries: Five‐year results from the ZOMAXX I trial
Identifieur interne : 004C51 ( Main/Merge ); précédent : 004C50; suivant : 004C52A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus‐ vs. Paclitaxel‐eluting stents in de novo occlusive lesions in coronary arteries: Five‐year results from the ZOMAXX I trial
Auteurs : Bernard Chevalier [France] ; Carlo Dimario [Royaume-Uni] ; Franz-Josef Neumann [Allemagne] ; Donald E. Cutlip [États-Unis] ; David O. Williams [États-Unis] ; John Ormiston [Nouvelle-Zélande] ; Eberhard Grube [Allemagne] ; Robert Whitbourn [Australie] ; Jessie Coe [États-Unis] ; Lewis B. Schwartz [États-Unis]Source :
- Catheterization and Cardiovascular Interventions [ 1522-1946 ] ; 2013-12-01.
Descripteurs français
- Wicri :
- topic : Polymère.
English descriptors
- KwdEn :
- Abbott laboratories, Acute stent thrombosis, Angiographic, Angiographic results, Angiography, Cardiac, Cardiac death, Cardiol, Cardiovasc, Cardiovascular, Cardiovascular angiography, Cardiovascular interventions, Catheterization, Chevalier, Clinical outcome, Clinical outcomes, Clinical results, Coll cardiol, Composite endpoint, Coronary arteries, Coronary artery disease, Coronary stent, Cutlip, Diameter stenosis, Endeavor stent, Endpoint, Final results, First year, Higher rate, Index procedure, Infarction, Interv, Jacc cardiovasc interv, Late lumen loss, Late stent thrombosis, Lesion, Long term, Lumen loss, Mace, Myocardial infarction, Occlusive lesions, Percutaneous, Polymer, Popma, Primary endpoint, Randomized, Reference vessel diameter, Restenosis, Scai, Stainless steel, Statistical significance, Stenosis, Stent, Stent thrombosis, Stented segment, Subacute stent thrombosis days, Target vessel, Taxus, Taxus group, Taxus stent, Taxus stents, Thrombosis, Zomaxx, Zomaxx group, Zomaxx stent, Zotarolimus.
- Teeft :
- Abbott laboratories, Acute stent thrombosis, Angiographic, Angiographic results, Angiography, Cardiac, Cardiac death, Cardiol, Cardiovasc, Cardiovascular, Cardiovascular angiography, Cardiovascular interventions, Catheterization, Chevalier, Clinical outcome, Clinical outcomes, Clinical results, Coll cardiol, Composite endpoint, Coronary arteries, Coronary artery disease, Coronary stent, Cutlip, Diameter stenosis, Endeavor stent, Endpoint, Final results, First year, Higher rate, Index procedure, Infarction, Interv, Jacc cardiovasc interv, Late lumen loss, Late stent thrombosis, Lesion, Long term, Lumen loss, Mace, Myocardial infarction, Occlusive lesions, Percutaneous, Polymer, Popma, Primary endpoint, Randomized, Reference vessel diameter, Restenosis, Scai, Stainless steel, Statistical significance, Stenosis, Stent, Stent thrombosis, Stented segment, Subacute stent thrombosis days, Target vessel, Taxus, Taxus group, Taxus stent, Taxus stents, Thrombosis, Zomaxx, Zomaxx group, Zomaxx stent, Zotarolimus.
Abstract
The ZOMAXX I trial tested the noninferiority of a zotarolimus‐eluting coronary stent (ZoMaxx™) when compared with a paclitaxel‐eluting coronary stent (Taxus™ Express2™) in a randomized trial of percutaneous intervention for de novo coronary artery stenosis. Angiographic analysis at the primary endpoint of 9 months has been reported previously. The purpose of this follow‐on analysis was to describe the clinical results of the ZoMaxx and Taxus cohorts of the ZOMAXX I trial after 5 years.
Url:
DOI: 10.1002/ccd.24958
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002881
- to stream Istex, to step Curation: 002881
- to stream Istex, to step Checkpoint: 000437
Links to Exploration step
ISTEX:DB0E0F8856B1782C6C8228D36DD4918D558C8C7DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus‐ vs. Paclitaxel‐eluting stents in de novo occlusive lesions in coronary arteries: Five‐year results from the ZOMAXX I trial</title>
<author><name sortKey="Chevalier, Bernard" sort="Chevalier, Bernard" uniqKey="Chevalier B" first="Bernard" last="Chevalier">Bernard Chevalier</name>
</author>
<author><name sortKey="Dimario, Carlo" sort="Dimario, Carlo" uniqKey="Dimario C" first="Carlo" last="Dimario">Carlo Dimario</name>
</author>
<author><name sortKey="Neumann, Franz Osef" sort="Neumann, Franz Osef" uniqKey="Neumann F" first="Franz-Josef" last="Neumann">Franz-Josef Neumann</name>
</author>
<author><name sortKey="Cutlip, Donald E" sort="Cutlip, Donald E" uniqKey="Cutlip D" first="Donald E." last="Cutlip">Donald E. Cutlip</name>
</author>
<author><name sortKey="Williams, David O" sort="Williams, David O" uniqKey="Williams D" first="David O." last="Williams">David O. Williams</name>
</author>
<author><name sortKey="Ormiston, John" sort="Ormiston, John" uniqKey="Ormiston J" first="John" last="Ormiston">John Ormiston</name>
</author>
<author><name sortKey="Grube, Eberhard" sort="Grube, Eberhard" uniqKey="Grube E" first="Eberhard" last="Grube">Eberhard Grube</name>
</author>
<author><name sortKey="Whitbourn, Robert" sort="Whitbourn, Robert" uniqKey="Whitbourn R" first="Robert" last="Whitbourn">Robert Whitbourn</name>
</author>
<author><name sortKey="Coe, Jessie" sort="Coe, Jessie" uniqKey="Coe J" first="Jessie" last="Coe">Jessie Coe</name>
</author>
<author><name sortKey="Schwartz, Lewis B" sort="Schwartz, Lewis B" uniqKey="Schwartz L" first="Lewis B." last="Schwartz">Lewis B. Schwartz</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:DB0E0F8856B1782C6C8228D36DD4918D558C8C7D</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1002/ccd.24958</idno>
<idno type="url">https://api.istex.fr/document/DB0E0F8856B1782C6C8228D36DD4918D558C8C7D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002881</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002881</idno>
<idno type="wicri:Area/Istex/Curation">002881</idno>
<idno type="wicri:Area/Istex/Checkpoint">000437</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000437</idno>
<idno type="wicri:doubleKey">1522-1946:2013:Chevalier B:a:randomized:controlled</idno>
<idno type="wicri:Area/Main/Merge">004C51</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus‐ vs. Paclitaxel‐eluting stents in de novo occlusive lesions in coronary arteries: Five‐year results from the ZOMAXX I trial</title>
<author><name sortKey="Chevalier, Bernard" sort="Chevalier, Bernard" uniqKey="Chevalier B" first="Bernard" last="Chevalier">Bernard Chevalier</name>
<affiliation wicri:level="1"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Cardio‐vasculaire, Paris‐Sud, Massy</wicri:regionArea>
<wicri:noRegion>Massy</wicri:noRegion>
<wicri:noRegion>Massy</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dimario, Carlo" sort="Dimario, Carlo" uniqKey="Dimario C" first="Carlo" last="Dimario">Carlo Dimario</name>
<affiliation wicri:level="2"><country>Royaume-Uni</country>
<placeName><region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Department of Cardiology, Royal Brompton Hospital, London</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Neumann, Franz Osef" sort="Neumann, Franz Osef" uniqKey="Neumann F" first="Franz-Josef" last="Neumann">Franz-Josef Neumann</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Herz‐Zentrum, Bad Krozingen, Bad Krozingen</wicri:regionArea>
<wicri:noRegion>Bad Krozingen</wicri:noRegion>
<wicri:noRegion>Bad Krozingen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cutlip, Donald E" sort="Cutlip, Donald E" uniqKey="Cutlip D" first="Donald E." last="Cutlip">Donald E. Cutlip</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Williams, David O" sort="Williams, David O" uniqKey="Williams D" first="David O." last="Williams">David O. Williams</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Rhode Island</region>
</placeName>
<wicri:cityArea>Cardiovascular Institute, Rhode Island Hospital, Providence</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Ormiston, John" sort="Ormiston, John" uniqKey="Ormiston J" first="John" last="Ormiston">John Ormiston</name>
<affiliation wicri:level="1"><country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>Department of Cardiology, Auckland City Hospital, Auckland</wicri:regionArea>
<wicri:noRegion>Auckland</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Grube, Eberhard" sort="Grube, Eberhard" uniqKey="Grube E" first="Eberhard" last="Grube">Eberhard Grube</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Heart Center Siegburg, Siegburg</wicri:regionArea>
<wicri:noRegion>Siegburg</wicri:noRegion>
<wicri:noRegion>Siegburg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Whitbourn, Robert" sort="Whitbourn, Robert" uniqKey="Whitbourn R" first="Robert" last="Whitbourn">Robert Whitbourn</name>
<affiliation wicri:level="3"><country xml:lang="fr">Australie</country>
<wicri:regionArea>Cardiac Investigation Unit, St. Vincent's Hospital, Melbourne</wicri:regionArea>
<placeName><settlement type="city">Melbourne</settlement>
<region type="état">Victoria (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Coe, Jessie" sort="Coe, Jessie" uniqKey="Coe J" first="Jessie" last="Coe">Jessie Coe</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Abbott Laboratories, Abbott Park</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Schwartz, Lewis B" sort="Schwartz, Lewis B" uniqKey="Schwartz L" first="Lewis B." last="Schwartz">Lewis B. Schwartz</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Illinois</region>
</placeName>
<wicri:cityArea>Abbott Laboratories, Abbott Park</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Catheterization and Cardiovascular Interventions</title>
<title level="j" type="alt">CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS</title>
<idno type="ISSN">1522-1946</idno>
<idno type="eISSN">1522-726X</idno>
<imprint><biblScope unit="vol">82</biblScope>
<biblScope unit="issue">7</biblScope>
<biblScope unit="page" from="1039">1039</biblScope>
<biblScope unit="page" to="1047">1047</biblScope>
<biblScope unit="page-count">9</biblScope>
<date type="published" when="2013-12-01">2013-12-01</date>
</imprint>
<idno type="ISSN">1522-1946</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1522-1946</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abbott laboratories</term>
<term>Acute stent thrombosis</term>
<term>Angiographic</term>
<term>Angiographic results</term>
<term>Angiography</term>
<term>Cardiac</term>
<term>Cardiac death</term>
<term>Cardiol</term>
<term>Cardiovasc</term>
<term>Cardiovascular</term>
<term>Cardiovascular angiography</term>
<term>Cardiovascular interventions</term>
<term>Catheterization</term>
<term>Chevalier</term>
<term>Clinical outcome</term>
<term>Clinical outcomes</term>
<term>Clinical results</term>
<term>Coll cardiol</term>
<term>Composite endpoint</term>
<term>Coronary arteries</term>
<term>Coronary artery disease</term>
<term>Coronary stent</term>
<term>Cutlip</term>
<term>Diameter stenosis</term>
<term>Endeavor stent</term>
<term>Endpoint</term>
<term>Final results</term>
<term>First year</term>
<term>Higher rate</term>
<term>Index procedure</term>
<term>Infarction</term>
<term>Interv</term>
<term>Jacc cardiovasc interv</term>
<term>Late lumen loss</term>
<term>Late stent thrombosis</term>
<term>Lesion</term>
<term>Long term</term>
<term>Lumen loss</term>
<term>Mace</term>
<term>Myocardial infarction</term>
<term>Occlusive lesions</term>
<term>Percutaneous</term>
<term>Polymer</term>
<term>Popma</term>
<term>Primary endpoint</term>
<term>Randomized</term>
<term>Reference vessel diameter</term>
<term>Restenosis</term>
<term>Scai</term>
<term>Stainless steel</term>
<term>Statistical significance</term>
<term>Stenosis</term>
<term>Stent</term>
<term>Stent thrombosis</term>
<term>Stented segment</term>
<term>Subacute stent thrombosis days</term>
<term>Target vessel</term>
<term>Taxus</term>
<term>Taxus group</term>
<term>Taxus stent</term>
<term>Taxus stents</term>
<term>Thrombosis</term>
<term>Zomaxx</term>
<term>Zomaxx group</term>
<term>Zomaxx stent</term>
<term>Zotarolimus</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Abbott laboratories</term>
<term>Acute stent thrombosis</term>
<term>Angiographic</term>
<term>Angiographic results</term>
<term>Angiography</term>
<term>Cardiac</term>
<term>Cardiac death</term>
<term>Cardiol</term>
<term>Cardiovasc</term>
<term>Cardiovascular</term>
<term>Cardiovascular angiography</term>
<term>Cardiovascular interventions</term>
<term>Catheterization</term>
<term>Chevalier</term>
<term>Clinical outcome</term>
<term>Clinical outcomes</term>
<term>Clinical results</term>
<term>Coll cardiol</term>
<term>Composite endpoint</term>
<term>Coronary arteries</term>
<term>Coronary artery disease</term>
<term>Coronary stent</term>
<term>Cutlip</term>
<term>Diameter stenosis</term>
<term>Endeavor stent</term>
<term>Endpoint</term>
<term>Final results</term>
<term>First year</term>
<term>Higher rate</term>
<term>Index procedure</term>
<term>Infarction</term>
<term>Interv</term>
<term>Jacc cardiovasc interv</term>
<term>Late lumen loss</term>
<term>Late stent thrombosis</term>
<term>Lesion</term>
<term>Long term</term>
<term>Lumen loss</term>
<term>Mace</term>
<term>Myocardial infarction</term>
<term>Occlusive lesions</term>
<term>Percutaneous</term>
<term>Polymer</term>
<term>Popma</term>
<term>Primary endpoint</term>
<term>Randomized</term>
<term>Reference vessel diameter</term>
<term>Restenosis</term>
<term>Scai</term>
<term>Stainless steel</term>
<term>Statistical significance</term>
<term>Stenosis</term>
<term>Stent</term>
<term>Stent thrombosis</term>
<term>Stented segment</term>
<term>Subacute stent thrombosis days</term>
<term>Target vessel</term>
<term>Taxus</term>
<term>Taxus group</term>
<term>Taxus stent</term>
<term>Taxus stents</term>
<term>Thrombosis</term>
<term>Zomaxx</term>
<term>Zomaxx group</term>
<term>Zomaxx stent</term>
<term>Zotarolimus</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Polymère</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">The ZOMAXX I trial tested the noninferiority of a zotarolimus‐eluting coronary stent (ZoMaxx™) when compared with a paclitaxel‐eluting coronary stent (Taxus™ Express2™) in a randomized trial of percutaneous intervention for de novo coronary artery stenosis. Angiographic analysis at the primary endpoint of 9 months has been reported previously. The purpose of this follow‐on analysis was to describe the clinical results of the ZoMaxx and Taxus cohorts of the ZOMAXX I trial after 5 years.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004C51 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 004C51 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:DB0E0F8856B1782C6C8228D36DD4918D558C8C7D |texte= A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus‐ vs. Paclitaxel‐eluting stents in de novo occlusive lesions in coronary arteries: Five‐year results from the ZOMAXX I trial }}
This area was generated with Dilib version V0.6.33. |